Copyright
©The Author(s) 2016.
World J Hepatol. Sep 8, 2016; 8(25): 1075-1086
Published online Sep 8, 2016. doi: 10.4254/wjh.v8.i25.1075
Published online Sep 8, 2016. doi: 10.4254/wjh.v8.i25.1075
Recommendation | Description |
A | The consensus strongly recommends the mentioned intervention or service. This recommendation is based on high quality evidence, with a benefit that significantly exceeds the risks |
B | The consensus recommends the regular clinical use of the mentioned intervention or service. This recommendation is based on moderate quality evidence, with a benefit that exceeds the risks |
C | The consensus does not make any positive or negative recommendation regarding the mentioned intervention or service. A categorical recommendation is not provided, because the evidence (of at least moderate quality) does not show a satisfactory risk/benefit relationship. The decision has to be made on a case-by-case basis |
D | The consensus makes a negative recommendation against the mentioned intervention or service. The recommendation is based on at least moderate quality evidence, not showing any benefit or where the risk or damage exceeds the benefits of the intervention |
I | The consensus concludes that the evidence is insufficient, due to low-quality studies, heterogeneous results or because the risk/benefit balance cannot be determined |
- Citation: Arab JP, Claro JC, Arancibia JP, Contreras J, Gómez F, Muñoz C, Nazal L, Roessler E, Wolff R, Arrese M, Benítez C. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World J Hepatol 2016; 8(25): 1075-1086
- URL: https://www.wjgnet.com/1948-5182/full/v8/i25/1075.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i25.1075